Detalhe da pesquisa
1.
Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
Int J Mol Sci
; 20(15)2019 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31370326
2.
Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis.
FASEB J
; 28(12): 5136-47, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25122558
3.
The Anti-Microbial Peptide LL-37/CRAMP Is Elevated in Patients with Liver Diseases and Acts as a Protective Factor during Mouse Liver Injury.
Digestion
; 91(4): 307-17, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25998843
4.
Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74.
Proc Natl Acad Sci U S A
; 108(42): 17444-9, 2011 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21969590
5.
Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice.
Hepatology
; 55(5): 1610-9, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22237831
6.
The chemokine receptor CXCR3 limits injury after acute toxic liver damage.
Lab Invest
; 92(5): 724-34, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22430509
7.
Extracellular Vesicles from Steatotic Hepatocytes Provoke Pro-Fibrotic Responses in Cultured Stellate Cells.
Biomolecules
; 12(5)2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35625625
8.
Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma.
Br J Pharmacol
; 178(22): 4452-4467, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250589
9.
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.
Cells
; 10(2)2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33525493
10.
Characterization of adipose tissue macrophages and adipose-derived stem cells in critical wounds.
PeerJ
; 5: e2824, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28070458
11.
The chemokine CCL3 promotes experimental liver fibrosis in mice.
PLoS One
; 8(6): e66106, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23799074
12.
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
Int J Clin Exp Pathol
; 6(4): 678-85, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23573314
13.
Interference with oligomerization and glycosaminoglycan binding of the chemokine CCL5 improves experimental liver injury.
PLoS One
; 7(5): e36614, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22574195
14.
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.
J Clin Invest
; 120(11): 4129-40, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20978355